← Back to Clinical Trials
Recruiting NCT07421765

NCT07421765 Interaction Between Atypical Work Schedules and/or Idel Time at Work on At-risk Gambling Practices

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07421765
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire de Nīmes
Condition Gambling
Study Type OBSERVATIONAL
Enrollment 25 participants
Start Date 2026-02-05
Primary Completion 2027-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
semi-structured interview

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 25 participants in total. It began in 2026-02-05 with a primary completion date of 2027-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

At-risk gambling causes individual and social harm, influenced by environmental, psychological, and socioeconomic factors. In France, 5% of adult gamblers show at-risk gambling practices. Atypical work schedules and idle time at work could increase this risk, but few studies have explored this. These working conditions impact the mental and cognitive health of workers, potentially contributing to at-risk gambling, especially during periods of idle time The study authors wish to explore the links between atypical work schedules, idle time at work, and at-risk gambling practices, considering social norms and individual vulnerabilities.

Eligibility Criteria

Inclusion Criteria: * Living with current or remission gambling, as assessed using the Problem Gambling Index Scale (PGSI) score of ≥5 * Having been employed during the current year * Patients with a personal mobile phone number and email address who agree to share them for research Exclusion Criteria: * Patient in an exclusion period determined by another study * Patient who has expressed their opposition to participating in this research

Contact & Investigator

Central Contact

Amandine Luquiens

✉ amandine.luquiens@chu-nimes.fr

📞 04.66.68.69.98

Principal Investigator

Amandine Luquiens

PRINCIPAL INVESTIGATOR

Centre Hospitalier Universitaire de Nīmes

Frequently Asked Questions

Who can join the NCT07421765 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Gambling. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07421765 currently recruiting?

Yes, NCT07421765 is actively recruiting participants. Contact the research team at amandine.luquiens@chu-nimes.fr for enrollment information.

Where is the NCT07421765 trial being conducted?

This trial is being conducted at Nantes, France, Nîmes, France.

Who is sponsoring the NCT07421765 clinical trial?

NCT07421765 is sponsored by Centre Hospitalier Universitaire de Nīmes. The principal investigator is Amandine Luquiens at Centre Hospitalier Universitaire de Nīmes. The trial plans to enroll 25 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology